Article Information
PubMed
Published By
History
- Received September 27, 2016
- Revision received May 26, 2017
- Accepted May 30, 2017
- First published June 12, 2017.
- Version of record published July 12, 2017.
Copyright & Usage
Copyright © 2017 the authors 0270-6474/17/376729-12$15.00/0
Author Information
- Grace O. Iyirhiaro1,
- Doo Soon Im1,
- Wassamon Boonying1,
- Steve M. Callaghan1,
- Matthew J. During2,
- Ruth S. Slack1, and
- David S. Park1
- 1University of Ottawa Brain and Mind Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada, and
- 2Department of Molecular Virology, Immunology and Medical Genetics, and Neurological Surgery, College of Medicine, The Ohio State University, Columbus, Ohio 43210
Author contributions
Author contributions: G.O.I., R.S.S., and D.S.P. designed research; G.O.I., D.S.I., W.B., S.M.C., and M.J.D. performed research; G.O.I. analyzed data; G.O.I. wrote the paper.
Disclosures
- Received September 27, 2016.
- Revision received May 26, 2017.
- Accepted May 30, 2017.
This work was supported by grants from the Heart and Stroke Foundation of Canada, the Heart and Stroke Foundation of Ontario (HSFO), the Canadian Institutes of Health Research, and the Krembil Foundation/Brain Canada (to D.S.P.). D.S.P. is an HSFO scholar. We thank Dr. Helen Piwnica-Worms, Washington University School of Medicine in St. Louis, for generously providing us with Cdc25B/C transgenic mice. We also thank Carmen Estey for technical assistance.
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. David S. Park, Department of Cellular and Molecular Medicine, Neuroscience, University of Ottawa, 451 Smyth Road, Ottawa, ON K1H 8M5, Canada. dpark{at}uottawa.ca
Other Version
- previous version (June 12, 2017).
- previous version (June 13, 2017).
- You are viewing the most recent version of this article.
Online Impact